Showing results (131-140 of 146) with videos related to
Sort By:
Pageof 15
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 15, 2021
Long-term risks after kidney donation: how do we inform potential donors? A survey from DESCARTES and EKITA transplantation working groupsGeir Mjøen, Umberto Maggiore, Nicos Kessaris, et al.Clinical Kidney Journal|February 11, 2021
A roadmap for optimizing chronic kidney disease patient care and patient-oriented research in the Eastern European nephrology communityMehmet Şükrü Sever, Kitty J Jager, Raymond Vanholder, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 31, 2021
Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessmentMarion Pépin, Ana Carina Ferreira, Mustafa Arici, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 5, 2020
Funding kidney research as a public health priority: challenges and opportunitiesCarmine Zoccali, Raymond Vanholder, Carsten A Wagner, et al.Scientific Reports|December 7, 2017
Association of kidney fibrosis with urinary peptides: a path towards non-invasive liquid biopsies?Pedro Magalhães, Martin Pejchinovski, Katerina Markoska, et al.Seminars in Dialysis|August 28, 2009
The role of EUTox in uremic toxin researchRaymond Vanholder, Omar Abou-Deif, Angel Argiles, et al.Bone|May 30, 2025
Bone histomorphometry for the diagnosis of renal osteodystrophy - a European consensus statementMarie-Helene Lafage-Proust, Hanne Skou Jørgensen, Nathalie Bravenboer, et al.Journal of the American Society of Nephrology : JASN|January 16, 2015
Diagnosis and Prediction of CKD Progression by Assessment of Urinary PeptidesJoost P Schanstra, Petra Zürbig, Alaa Alkhalaf, et al.The Lancet. Diabetes & Endocrinology|March 6, 2020
Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trialNete Tofte, Morten Lindhardt, Katarina Adamova, et al.Journal of Diabetes and Its Complications|February 25, 2023
Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria - A post-hoc analysis of the PRIORITY randomized clinical trialViktor Rotbain Curovic, Nete Tofte, Morten Lindhardt, et al.Pageof 15